LDP Committee Approves 2013 Budget With Increases For New Drug Discovery
This article was originally published in PharmAsia News
Executive Summary
The Liberal Democratic Party’s Health, Labor, and Welfare Committee generally approved Jan. 9 the draft for new projects in Japan’s budget for 2013, presented to the group by the Ministry of Health, Labor, and Welfare.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.